2026. Suspected Optic Nerve Dysfunction Associated with Semaglutide in a Non-Diabetic Obese Patient: A Case Report: Semaglutide Associated Optic Nerve Dysfunction. Journal of Diabesity. 1, 2 (Feb. 2026).